Corinne Lehmann, MD, MEd

Director, Medical Student Education (Clerkship Director), Department of Pediatrics, UC College of Medicine

Medical Director, Family Care Center for Pediatric and Adolescent HIV

Associate Professor, UC Department of Pediatrics

Phone: 513-636-8591


Show All


HIV care: pediatric, adolescent and adult medical education


Corinne Lehmann, MD, MEd, is the director of Medical Student Education in the Department of Pediatrics for the University of Cincinnati College of Medicine (UCCOM), where she maintains oversight of the third-year clerkship and fourth-year electives. She directs a Medical Student Scholars Program in Pediatrics for students at UCCOM and serves as advisor for several medical students and pediatrics residents.

Dr. Lehmann’s clinical duties include precepting at the Teen Health Center, patient care and precepting at the UC Infectious Disease Center for adult HIV care, and directing the Family Care Center for Pediatric and Adolescent HIV at Cincinnati Children’s Hospital Medical Center (CCHMC). She gives numerous lectures to students, residents, colleagues and other health care professionals in the local, regional and national arenas regarding perinatal HIV transmission and the clinical/transitional care of HIV-infected children and adolescents. Her interests in clinical research center on the study of pediatric and adolescent HIV, and she has been involved in vaccine research with the Division of Infectious Diseases at CCHMC. Her research endeavors in medical education focus on the use of Standardized Patients, simulation and feedback as instructional tools.

Education and Training

MEd: University of Cincinnati, Cincinnati, OH, 2005.

MD: University of Cincinnati, Cincinnati, Ohio, 1993.

Residency: University of Cincinnati, Cincinnati, Ohio, 1997.

Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 2002.


View PubMed Publications


Health-based survey of families living within 10km of dispensary in western Kenya. Mentor. National Institutes of Health. June 2011 - August 2011.

A randomized, double-blinded, controlled, phase I study in healthy adults to assess the safety, reactogenicity, and immunogenicity of intramuscular subvirion inactivated monovalent influenza A/H5N1 virus vaccine administered at different dose levels given with and without MF59 adjuvant. Secondary Independent Safety Monitor. National Institutes of Health. April 2011 - April 2012.

A randomized, double-blind trial comparing the safety in mothers and their infants and immunogenicity in mothers of live attenuated influenza vaccine (LAIV) to inactivated trivalent influenza vaccine (TIV) when administered to breastfeeding women. Secondary Independent Safety Monitor. National Institutes of Health. May 2011 - May 2012.